CMBA
IRWD icon

C.M. Bidwell & Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

C.M. Bidwell & Associates’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$947 Buy
+225
New +$867 ﹤0.01% 443
2021
Q4 		– Sell
-6,360
Closed -$83K – 588
2021
Q3 		$83K Buy
+6,360
New +$82.2K 0.06% 249

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

C.M. Bidwell & Associates's IRWD Position: Q2 2026 in Review

C.M. Bidwell & Associates opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 225 shares worth $947. The stake represents ﹤0.01% of the portfolio and ranks #443 among its holdings. This is a return to the name: C.M. Bidwell & Associates previously reported a position in IRWD as recently as Q3 2021.

C.M. Bidwell & Associates first reported a position in IRWD in Q3 2021 and has held it in 2 quarters since. The position peaked at $83K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • C.M. Bidwell & Associates held 225 shares of Ironwood Pharmaceuticals worth $947 as of Q2 2026.
  • Ironwood Pharmaceuticals was a new C.M. Bidwell & Associates position in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #443 holding.
  • C.M. Bidwell & Associates first reported a position in Ironwood Pharmaceuticals in Q3 2021 and has held it in 2 quarters since.
  • C.M. Bidwell & Associates's Ironwood Pharmaceuticals position peaked at $83K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.